See news from the full history of Samplix, covering all the conferences we've attended, new product launches, and more.
October 28, 2022 – There are still opportunities to connect with Samplix representatives in November. We're at the following conferences.
Looking forward to seeing you there!
June 20, 2022 – When you want to co-encapsulate two cell types in double-emulsion droplets — for example, natural killer cells and their targets — we have an elegantly simple accessory to go with our Xdrop DE50 Cartridge.
The well insert ensures that the two cell types do not interact until they've been co-encapsulated within double-emulsion droplets, where their interactions can be observed with single-cell resolution.
March 23, 2022 – Achieve single-cell resolution for functional assays of mammalian cells with the newly launched Xdrop DE50 Cartridge. It is designed for encapsulating single living mammalian cells in highly stable double-emulsion droplets.
This new microfluidics solution has enormous potential for mammalian cell work. It opens up the exciting possibility to transform bulk mammalian cell assays into single-cell assays focused on the potency of engineered cells. What's more, the desired cells can be retrieved for further expansion. We've already performed functional assays on encapsulated cells, such as cytokine secretion and cell killing assays, to prove the utility of this new microfluidics-based approach.
March 16, 2022 – Samplix representatives are attending the following conferences and events in 2022. Watch this space for more information on our booth, talks, and other plans.
March 8, 2022 – The theme for International Women's Day 2022 is #BreakTheBias: whether deliberate or unconscious, the bias against women at a sociopolitical level makes the path to success harder. The organizers of the day are calling on people the world over to try to make a difference by caling out gender bias, discrimination and stereotyping whenever we see it.
Even small companies like Samplix can do something to make a difference and #BreakTheBias. It's vital to take gender bias seriously, and we've tried to do that.
At every level of the company, including senior management, there are women whose ideas help shape strategy and tactics. We all strive to listen to each other's concepts and concerns. Our managers work to empower the brilliant scientists, technicians, application specialists, salespeople, and marketers reporting to them. We interview broadly when advertising new positions and if the demographics of the applicants are limited, we try to ask why. And crucially, we actively try to hire people with different viewpoints so the managers can continuously be challenged on their own ideas.
No organization or individual is perfect in this vital area of equality and inclusion. But it's essential that we all try to create workplaces where everyone thrives without bias.
January 25, 2022 – We are delighted to announce the launch of our new instrument, Xdrop Sort and its microfluidics cartridge, Xdrop DE20 Sort: the next generation in gene and cell screening technology.
Uniquely, Xdrop Sort enables both the encapsulation and sorting of biological material, such as DNA and small cells, within stable double-emulsion droplets.
Together with appropriate sequencing or enzyme analytics technologies, Xdrop Sort is designed for a whole range of high-throughput gene and cell screening applications.
With Xdrop Sort, researchers can more easily reach the highest-resolution insights into the cells and genomes of humans, animals, plants, and microorganisms.
How can we better study genotype–phenotype correlation in genetic disorders and potentially enable more efficient diagnosis? Published in Frontiers in Genetics, this important paper details how to overcome the limitations of traditional methods for the analysis of repeat extensions using microfluidics droplet-based DNA preparation using Xdrop and sequencing using Oxford Nanopore Technologies and Illumina. The study was done by an inter-institutional team including researchers from the University of Verona, the University of Rome Tor Vergata, the University of Nevada at Reno, GENARTIS and IRCCS.
The Festival of Genomics and Biodata is the UK's largest genomics event. This year, the organizers decided to have the event in a virtual format due to the COVID-19 pandemic. Samplix fully supported their decision and took an active part in the event as a sponsor and exhibitor.
Dr. Lydia Teboul of MRC Harwell Institute spoke about her team's use of the Xdrop target enrichment workflow to map and characterize mouse transgenes. See Dr. Teboul's talk
Our CTO, Dr. Marie Just Mikkelsen, gave a lightning talk on how microfluidics technology is revolutionizing gene and cell screening. See Dr. Mikkelsen's talk
To facilitate the handling of Oxford Nanopore Technologies and Illumina data from Xdrop workflows, Samplix has launched a suite of dedicated bioinformatics tools that are free to use for our customers.
The suite includes tools for:
The SLAS Europe 2022 Conference is an important networking opportunity for people involved in lab automation and all the areas it relates to, including early drug discovery, cell biology, and molecular engineering. It was held at the RDS in Dublin from May 25–27.
We were delighted to be there, taking part as an exhibitor (at Booth K1, as pictured) and as a presenter. Our CTO, Dr. Marie Mikkelsen, gave an important talk presenting some of our latest results from functional analyses of mammalian cells encapsulated in our new DE50 droplets.
The organizers of the International Plant and Animal Genome XXIX took the difficult decision to move the conference to a virtual platform. Samplix supported their decision and wished the organizers and attendees an excellent experience. We're looking forward to next year's conference and exhibition.
November 16-18
The second international conference on Microbial Food and Feed Ingredients (MiFFI) was in Copenhagen. Samplix experts were at Booth C2 to answer questions and demonstrate how microfluidics technology can boost the resolution and throughput of single-cell investigations and synthetic biology workflows.
